Tag: HTA

Plenary Sessions and Speakers Announced for ISPOR 20th Annual European Congress

Conference to Explore The Evolution of Value in Health Care on 4-8 November 2017 in Glasgow, Scotland Princeton, NJ—September 18, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 20th Annual European Congress

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

What Can We Learn From Global Health Care Systems?

A Look at Health Care Systems from Around the World Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a number of sessions at its 22nd Annual International Conference in Boston, MA, USA that focused on

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Developing and Paying for Gene Therapies: How to Measure Value?

Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session this morning at its 22nd Annual International Meeting in Boston, MA, USA that examined the issue of developing and paying for gene therapies.

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

New Study Identifies Notable Differences in How 6 European Health Agencies Assess Real-World Data

Report Includes Findings from TLV (Sweden), NICE (UK), IQWiG (Germany), HAS (France), AIFA (Italy), and ZIN (Netherlands) Princeton, NJ—April 18, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

ISPOR COMMENTS ON PROPOSED EUROPEAN UNION COOPERATION ON HEALTH TECHNOLOGY ASSESSMENT

Society’s Comments Emphasize Need for Ongoing Collaboration and Observation of HTA Good Practices   Princeton, NJ—January 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has submitted comments in response to the European Commission’s request for public consultation regarding

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

ISPOR ANNOUNCES NEW 2017 HEALTH ECONOMICS AND OUTCOMES RESEARCH TRAINING PROGRAMS

Princeton, NJ—December 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced  its upcoming health economics and outcomes research (HEOR) in-person training programs scheduled for early 2017.

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

ISPOR 19th ANNUAL EUROPEAN CONGRESS DREW KEY STAKEHOLDERS AND THOUGHT LEADERS TO DISCUSS ACCESS TO MEDICAL INNOVATIONS

Regulatory, Policy, and Financing Decisions in International Health Systems   Princeton, NJ—November 22, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently concluded its 19th Annual European Congress in Vienna, Austria. More than 4,700 delegates—stakeholders from all sectors of

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS FOCUSES ON THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT

Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel this afternoon entitled, Using Observational (Real-World) Data in Health Technology Assessment: Route to Confusion or Better Decisions? The session took place at the Society’s

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES INCLUSION OF FUTURE MEDICAL COSTS IN HEALTH TECHNOLOGY ASSESSMENT GUIDELINES

Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel entitled, Should Health Technology Assessment Guidelines Recommend Inclusion of Future Medical Costs?, at the Society’s 19th Annual European Congress in Vienna, Austria. 

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES USE OF MULTI-CRITERIA DECISION ANALYSIS TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT

Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning entitled, The Potential and Pitfalls of Using Multi-Criteria Decision Analysis to Support Health Technology Assessment. The session took place at the Society’s 19th

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,